PAHC Phibro Animal Health Corporation Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

PAHC [NASD]

Phibro Animal Health Corporation

Healthcare | Specialized Health Services | USA

financial highlights | statements

Index	-	P/E	26.26	EPS (ttm)	1.67	Insider Own	0.30%	Shs Outstand	39.64M	Perf Week	5.50%
Market Cap	1.74B	Forward P/E	23.16	EPS next Y	1.90	Insider Trans	-83.85%	Shs Float	20.07M	Perf Month	3.00%
Income	67.60M	PEG	3.98	EPS next Q	0.41	Inst Own	97.00%	Short Float	1.58%	Perf Quarter	-7.52%
Sales	820.00M	P/S	2.12	EPS this Y	3.70%	Inst Trans	-1.17%	Short Ratio	2.40	Perf Half Y	-0.16%
Book/sh	4.58	P/B	9.59	EPS next Y	8.03%	ROA	9.70%	Target Price	42.67	Perf Year	17.77%
Cash/sh	2.00	P/C	21.99	EPS next 5Y	6.60%	ROE	36.60%	52W Range	32.05 - 54.62	Perf YTD	31.13%
Dividend	0.40	P/FCF	49.19	EPS past 5Y	21.10%	ROI	15.80%	52W High	-19.57%	Beta	0.88
Dividend %	0.91%	Quick Ratio	1.70	Sales past 5Y	4.70%	Gross Margin	32.50%	52W Low	37.07%	ATR	1.17
Employees	1500	Current Ratio	2.90	Sales Q/Q	8.70%	Oper. Margin	12.10%	RSI (14)	48.96	Volatility	2.19% 2.70%
Optionable	Yes	Debt/Eq	1.69	EPS Q/Q	16.90%	Profit Margin	7.90%	Rel Volume	0.47	Prev Close	43.89
Shortable	Yes	LT Debt/Eq	1.62	Earnings	Nov 06 AMC	Payout	24.80%	Avg Volume	132.51K	Price	43.93
Recom	3.50	SMA20	2.17%	SMA50	-4.12%	SMA200	2.21%	Volume	62,613	Change	0.09%

Aug-23-17

Resumed

BofA/Merrill

Underperform

$33

Jun-02-17

Downgrade

Credit Suisse

Outperform → Neutral

Dec-15-16

Initiated

Piper Jaffray

Overweight

Nov-11-16

Downgrade

Macquarie

Neutral → Underperform

Nov-10-16

Downgrade

Gabelli & Co

Buy → Hold

Apr-11-16

Reiterated

Guggenheim

Buy

$38 → $34

Feb-04-16

Initiated

Credit Suisse

Outperform

Jan-15-16

Downgrade

Barclays

Overweight → Underweight

$36 → $31

Sep-30-15

Initiated

Gabelli & Co

Buy

$42

Apr-24-15

Reiterated

Barclays

Overweight

$22 → $36

Apr-21-15

Downgrade

Morgan Stanley

Equal-Weight → Underweight

May-06-14

Initiated

Barclays

Overweight

$21

Oct-18-18 09:51AM	Is Phibro Animal Health Corporation (NASDAQ:PAHC) A High Quality Stock To Own? Simply Wall St.
Oct-11-18 04:00PM	Phibro Animal Health Corporation to Participate in the Credit Suisse Healthcare Conference GlobeNewswire
Oct-10-18 08:20AM	Consolidated Research: 2018 Summary Expectations for Macerich, Deluxe, RadiSys, Lannett, Ambarella, and Phibro Animal Health Fundamental Analysis, Key Performance Indications GlobeNewswire
Oct-08-18 04:00PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2018 Quarterly Financial Results GlobeNewswire
Sep-26-18 09:30AM	Why Is Phibro (PAHC) Down 13.3% Since Last Earnings Report? Zacks
Sep-12-18 09:24AM	Calculating The Intrinsic Value Of Phibro Animal Health Corporation (NASDAQ:PAHC) Simply Wall St.
Sep-10-18 04:28PM	Edited Transcript of PAHC earnings conference call or presentation 28-Aug-18 1:00pm GMT Thomson Reuters StreetEvents
Aug-30-18 09:32AM	Here's Why You Should Invest in Phibro (PAHC) Right Now Zacks
Aug-28-18 12:22PM	Phibro Animal (PAHC) Q4 Earnings Beat, Sales Improve Y/Y Zacks -7.94%
07:00AM	Phibro Animal Health Corporation Class A to Host Earnings Call ACCESSWIRE
Aug-27-18 05:34PM	Phibro: Fiscal 4Q Earnings Snapshot Associated Press +5.42%
05:15PM	Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Presents Financial Guidance and Announces an Increased Dividend GlobeNewswire
Aug-13-18 04:00PM	Phibro Animal Health Corporation to Participate in the Morgan Stanley Annual Global Healthcare Conference GlobeNewswire
Aug-06-18 08:00AM	Analysis: Positioning to Benefit within BioTelemetry, Genworth Financial, Power Integrations, Phibro Animal Health, BlackRock, and The ExOne Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jul-30-18 05:00PM	Phibro Animal Health Corporation Declares Quarterly Dividend GlobeNewswire
Jul-06-18 04:00PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2018 Results GlobeNewswire
Jul-05-18 01:51PM	[$$] Phibro Plans Ireland Biotech Facility, Creating Up to 150 Jobs The Wall Street Journal
12:24PM	Phibro Animal Health to establish new biotech facility in Sligo, Ireland, creating up to 150 jobs GlobeNewswire
Jun-21-18 04:00PM	What Investors Should Know About Phibro Animal Health Corporations (NASDAQ:PAHC) Financial Strength Simply Wall St.
Jun-06-18 10:58AM	Why Is Phibro Animal (PAHC) Up 10.7% Since Its Last Earnings Report? Zacks
May-10-18 03:35AM	Edited Transcript of PAHC earnings conference call or presentation 8-May-18 1:00pm GMT Thomson Reuters StreetEvents
May-08-18 10:38AM	Phibro Animal (PAHC) Q3 Earnings Beat, Sales Improve Y/Y Zacks +5.11%
May-07-18 06:27PM	Phibro: Fiscal 3Q Earnings Snapshot Associated Press
04:20PM	Phibro Animal Health Corporation Declares Quarterly Dividend GlobeNewswire
04:15PM	Phibro Animal Health Corporation Reports Third Quarter GlobeNewswire
07:48AM	Phibro Animal Health Earnings Preview Benzinga
Apr-30-18 08:00AM	Research Report Identifies Albany International, JBG SMITH Properties, Preferred Apartment Communities, National Western Life Group, Phibro Animal Health, and Imprimis Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-19-18 05:00PM	Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2018 Health Care Conference GlobeNewswire
Apr-03-18 04:00PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on March 2018 Quarterly Financial Results GlobeNewswire
Mar-29-18 07:53AM	Zacks.com featured highlights include: Archer Daniels, Phibro Animal, NEXEO, Western Digital and Fortinet Zacks
Mar-28-18 08:24AM	5 Stocks Near 52-Week High: Is More Upside Left? Zacks
Mar-20-18 12:14PM	Here's Why Phibro Animal Health is Worth a Buy Right Now Zacks
07:35AM	Investor Expectations to Drive Momentum within Key Energy Services, XOMA, Goldman Sachs BDC, Echo Global Logistics, Ellington Residential Mortgage REIT, and Phibro Animal Health Discovering Underlying Factors of Influence GlobeNewswire
Mar-12-18 10:52AM	5 Growth Stocks in MedTech Set to Scale Higher in 2018 Zacks
Mar-07-18 09:27AM	Phibro Animal Health (PAHC) Up 7% Since Earnings Report: Can It Continue? Zacks
Mar-02-18 06:19AM	Is Phibro Animal Health Corporation (NASDAQ:PAHC) A Sell At Its Current PE Ratio? Simply Wall St.
Feb-28-18 07:10AM	Free Research Report as Phibro Animal Healths Sales Jumped7%; Adjusted EPS Advanced 12.8% ACCESSWIRE
Feb-26-18 12:06PM	Edited Transcript of PAHC earnings conference call or presentation 6-Feb-18 2:00pm GMT Thomson Reuters StreetEvents
Feb-06-18 02:00PM	Phibro Animal Health Corporation to Participate in Bank of America Merrill Lynch 2018 Animal Health Summit GlobeNewswire +12.89%
09:59AM	Phibro Animal (PAHC) Beats on Q2 Earnings, Raises Guidance Zacks
07:15AM	Phibro Animal Health Corporation Class A to Host Earnings Call ACCESSWIRE
Feb-05-18 04:38PM	Phibro beats 2Q profit forecasts Associated Press -5.43%
04:35PM	Phibro Animal Health Corporation Declares Quarterly Dividend GlobeNewswire
04:25PM	Phibro Animal Health Corporation Reports Second Quarter and Updated Annual Financial Guidance GlobeNewswire
Feb-01-18 08:41AM	Should You Sell Phibro Animal Health (PAHC) Before Earnings? Zacks
Jan-17-18 07:30AM	New Research Coverage Highlights INTL FCStone, Phibro Animal Health, Tactile Systems Technology, RadiSys, Proto Labs, and Weingarten Realty Investors Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Jan-09-18 08:00AM	Phibro (PAHC) Strong on Animal Health Arm, Dull MFA Ails Zacks
Jan-02-18 04:00PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2017 Quarterly Financial Results GlobeNewswire
Dec-25-17 08:05AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Dec-22-17 08:07AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Dec-18-17 04:07PM	ETFs with exposure to Phibro Animal Health Corp. : December 18, 2017 Capital Cube +5.70%
Dec-06-17 10:54AM	Phibro Animal Health Corp. : PAHC-US: Dividend Analysis : December 06th, 2017 (record date) : By the numbers : December 6, 2017 Capital Cube
Dec-01-17 07:40AM	Calculating The Fair Value Of Phibro Animal Health Corporation (PAHC) Simply Wall St.
Nov-28-17 08:05AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Nov-27-17 03:14PM	ETFs with exposure to Phibro Animal Health Corp. : November 27, 2017 Capital Cube
Nov-24-17 08:26AM	Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q1, 2018 By the Numbers : November 24, 2017 Capital Cube
Nov-21-17 08:06AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Nov-10-17 08:16AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Nov-09-17 03:52PM	Dull MFA & Mineral Nutrition Sales Hurt Phirbo, Rivalry Rife Zacks
Nov-08-17 06:38PM	Edited Transcript of PAHC earnings conference call or presentation 7-Nov-17 2:00pm GMT Thomson Reuters StreetEvents
Nov-07-17 09:00AM	Phibro Animal (PAHC) Beats on Q1 Earnings, Reiterates View Zacks -5.41%
07:10AM	Phibro Animal Health Corporation Class A to Host Earnings Call ACCESSWIRE
Nov-06-17 05:49PM	Phibro beats 1Q profit forecasts Associated Press
04:20PM	Phibro Animal Health Corporation Declares Quarterly Dividend GlobeNewswire
04:15PM	Phibro Animal Health Corporation Reports First Quarter GlobeNewswire
Oct-31-17 08:19AM	Phibro Animal Health Corp. breached its 50 day moving average in a Bearish Manner : PAHC-US : October 31, 2017 Capital Cube
Oct-20-17 10:32AM	Phibro Animal Health Corp. Value Analysis (NASDAQ:PAHC) : October 20, 2017 Capital Cube
Oct-17-17 09:11AM	Phibro Animal Banks on Diverse Portfolio, Competition Rife Zacks
08:02AM	Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 17, 2017 Capital Cube
Oct-16-17 04:00PM	Phibro Animal Health Corporation to Participate in the Credit Suisse Healthcare Conference GlobeNewswire
Oct-05-17 08:04AM	Phibro Animal Health Corp. breached its 50 day moving average in a Bullish Manner : PAHC-US : October 5, 2017 Capital Cube
Oct-03-17 04:30PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2017 Quarterly Financial Results GlobeNewswire
08:05AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Oct-02-17 08:04AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
03:31AM	Phibro (PAHC) Down 2.7% Since Earnings Report: Can It Continue? Zacks
Sep-21-17 07:00AM	Earnings Review and Free Research Report: Phibro Animal Healths Net Sales Grew 3%; Adjusted EPS Surged 22% ACCESSWIRE
Sep-15-17 10:08AM	Phibro Animal Health Expands Globally Amid Tough Competition Zacks
Sep-12-17 01:31PM	Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: Q4, 2017 By the Numbers : September 12, 2017 Capital Cube
08:04AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Sep-11-17 08:04AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Sep-07-17 01:43PM	ETFs with exposure to Phibro Animal Health Corp. : September 7, 2017 Capital Cube
Sep-06-17 09:53AM	Phibro Animal Health Corp. :PAHC-US: Earnings Analysis: 2017 By the Numbers : September 6, 2017 Capital Cube
08:05AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Sep-05-17 08:04AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Sep-04-17 08:04AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Aug-31-17 10:00PM	Edited Transcript of PAHC earnings conference call or presentation 31-Aug-17 1:00pm GMT Thomson Reuters StreetEvents -5.96%
08:04PM	Phibro beats 4Q profit forecasts Associated Press
10:33AM	Phibro Animal (PAHC) Beats Q4 Earnings & Sales Estimates Zacks
07:15AM	Investor Network: Phibro Animal Health Corporation Class A to Host Earnings Call ACCESSWIRE
Aug-30-17 05:21PM	Phibro Animal Health Corp. Value Analysis (NASDAQ:PAHC) : August 30, 2017 Capital Cube
04:15PM	Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year GlobeNewswire
Aug-24-17 08:44AM	Phibro Animal Health Corp. breached its 50 day moving average in a Bearish Manner : PAHC-US : August 24, 2017 Capital Cube
Aug-12-17 08:04AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Aug-10-17 08:05AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Aug-09-17 06:00PM	Phibro Animal Health Corporation to Participate in the Morgan Stanley 2017 Global Healthcare Conference GlobeNewswire
08:05AM	See what the IHS Markit Score report has to say about Phibro Animal Health Corp. Markit
Jul-24-17 04:15PM	Phibro Animal Health Corporation Declares Quarterly Dividend GlobeNewswire
Jul-07-17 07:25AM	Phibro Animal Health & Zydus Cadila Plan to Expand in India Zacks
Jul-06-17 04:00PM	Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2017 Results GlobeNewswire
Jul-05-17 08:15AM	Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibros Poultry Vaccine Technologies GlobeNewswire

Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It also operates in Israel, Latin America, Canada, Europe, Africa, and the Asia/Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. The company is headquartered in Teaneck, New Jersey. Phibro Animal Health Corporation is a subsidiary of BFI Co., LLC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Bendheim Daniel M	Exec. VP, Corporate Strategy	Sep 12	Option Exercise	11.83	2,500	29,575	2,500	Sep 14 09:04 PM
BENDHEIM JACK	President and CEO	Sep 12	Sale	45.04	520	23,421	59,480	Sep 14 09:03 PM
BFI Co., LLC	10% Owner	Sep 12	Sale	45.04	520	23,421	59,480	Sep 14 09:04 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Sep 12	Sale	44.30	2,500	110,750	0	Sep 14 09:04 PM
BFI Co., LLC	10% Owner	Sep 06	Sale	46.97	10,000	469,718	30,000	Sep 06 09:24 PM
BENDHEIM JACK	President and CEO	Sep 06	Sale	46.97	10,000	469,718	30,000	Sep 06 09:26 PM
BFI Co., LLC	10% Owner	Sep 05	Sale	47.30	10,000	473,000	40,000	Sep 06 09:24 PM
BENDHEIM JACK	President and CEO	Sep 05	Sale	47.30	10,000	473,000	40,000	Sep 06 09:26 PM
BFI Co., LLC	10% Owner	Aug 23	Sale	49.84	10,000	498,400	30,000	Aug 23 09:18 PM
BENDHEIM JACK	President and CEO	Aug 23	Sale	49.84	10,000	498,400	30,000	Aug 23 09:18 PM
BFI Co., LLC	10% Owner	Aug 22	Sale	49.92	10,000	499,200	40,000	Aug 23 09:18 PM
BENDHEIM JACK	President and CEO	Aug 22	Sale	49.92	10,000	499,200	40,000	Aug 23 09:18 PM
BFI Co., LLC	10% Owner	Aug 21	Sale	50.35	10,000	503,500	50,000	Aug 23 09:18 PM
BENDHEIM JACK	President and CEO	Aug 21	Sale	50.35	10,000	503,500	50,000	Aug 23 09:18 PM
BFI Co., LLC	10% Owner	Aug 15	Sale	49.33	10,000	493,300	30,000	Aug 15 09:09 PM
BENDHEIM JACK	President and CEO	Aug 15	Sale	49.33	10,000	493,300	30,000	Aug 15 09:11 PM
BFI Co., LLC	10% Owner	Aug 14	Sale	49.90	10,000	499,000	40,000	Aug 15 09:09 PM
BENDHEIM JACK	President and CEO	Aug 14	Sale	49.90	10,000	499,000	40,000	Aug 15 09:11 PM
BENDHEIM JACK	President and CEO	Aug 13	Sale	50.03	10,000	500,300	50,000	Aug 15 09:11 PM
BFI Co., LLC	10% Owner	Aug 13	Sale	50.03	10,000	500,300	50,000	Aug 15 09:09 PM
BENDHEIM JACK	President and CEO	Aug 08	Sale	49.82	10,000	498,200	0	Aug 08 09:11 PM
BFI Co., LLC	10% Owner	Aug 08	Sale	49.82	10,000	498,200	0	Aug 08 09:09 PM
BENDHEIM JACK	President and CEO	Aug 07	Sale	50.12	10,000	501,155	10,000	Aug 08 09:11 PM
BFI Co., LLC	10% Owner	Aug 07	Sale	50.12	10,000	501,155	10,000	Aug 08 09:09 PM
BENDHEIM JACK	President and CEO	Aug 06	Sale	50.66	10,000	506,600	8,000	Aug 08 09:11 PM
BFI Co., LLC	10% Owner	Aug 06	Sale	50.66	10,000	506,600	8,000	Aug 08 09:09 PM
BENDHEIM JACK	President and CEO	Jul 27	Sale	47.07	4,000	188,280	18,000	Jul 27 09:10 PM
BFI Co., LLC	10% Owner	Jul 27	Sale	47.07	4,000	188,280	18,000	Jul 27 09:09 PM
BENDHEIM JACK	President and CEO	Jul 26	Sale	47.61	4,000	190,440	22,000	Jul 27 09:10 PM
BFI Co., LLC	10% Owner	Jul 26	Sale	47.61	4,000	190,440	22,000	Jul 27 09:09 PM
BENDHEIM JACK	President and CEO	Jul 25	Sale	47.37	4,000	189,480	26,000	Jul 27 09:10 PM
BFI Co., LLC	10% Owner	Jul 25	Sale	47.37	4,000	189,480	26,000	Jul 27 09:09 PM
BFI Co., LLC	10% Owner	Jul 19	Sale	47.22	4,000	188,880	30,000	Jul 19 09:02 PM
BENDHEIM JACK	President and CEO	Jul 19	Sale	47.22	4,000	188,880	30,000	Jul 19 09:01 PM
BFI Co., LLC	10% Owner	Jul 18	Sale	47.95	4,000	191,800	34,000	Jul 19 09:02 PM
BENDHEIM JACK	President and CEO	Jul 18	Sale	47.95	4,000	191,800	34,000	Jul 19 09:01 PM
BFI Co., LLC	10% Owner	Jul 17	Sale	48.20	9,470	456,454	38,000	Jul 19 09:02 PM
BENDHEIM JACK	President and CEO	Jul 17	Sale	48.20	9,470	456,454	38,000	Jul 19 09:01 PM
BENDHEIM JACK	President and CEO	Jul 11	Sale	46.89	10,000	468,900	30,000	Jul 11 08:14 PM
BFI Co., LLC	10% Owner	Jul 11	Sale	46.89	10,000	468,900	30,000	Jul 11 08:11 PM
BENDHEIM JACK	President and CEO	Jul 10	Sale	46.81	10,000	468,100	40,000	Jul 11 08:14 PM
BFI Co., LLC	10% Owner	Jul 10	Sale	46.81	10,000	468,100	40,000	Jul 11 08:11 PM
BENDHEIM JACK	President and CEO	Jul 09	Sale	46.96	10,000	469,600	50,000	Jul 11 08:14 PM
BFI Co., LLC	10% Owner	Jul 09	Sale	46.96	10,000	469,600	50,000	Jul 11 08:11 PM
Warras Dean J	Pres Animal Health & Nutr N.A.	Jul 02	Option Exercise	11.83	10,000	118,300	10,000	Jul 05 06:09 PM
Warras Dean J	Pres Animal Health & Nutr N.A.	Jul 02	Sale	46.38	10,000	463,850	0	Jul 05 06:09 PM
BENDHEIM JACK	President and CEO	Jun 29	Sale	45.65	10,000	456,500	30,000	Jun 29 09:14 PM
BFI Co., LLC	10% Owner	Jun 29	Sale	45.65	10,000	456,500	30,000	Jun 29 09:13 PM
BENDHEIM JACK	President and CEO	Jun 28	Sale	45.54	10,000	455,400	40,000	Jun 29 09:14 PM
BFI Co., LLC	10% Owner	Jun 28	Sale	45.54	10,000	455,400	40,000	Jun 29 09:13 PM
BENDHEIM JACK	President and CEO	Jun 27	Sale	45.79	10,000	457,900	50,000	Jun 29 09:14 PM
BFI Co., LLC	10% Owner	Jun 27	Sale	45.79	10,000	457,900	50,000	Jun 29 09:13 PM
BFI Co., LLC	10% Owner	Jun 21	Sale	47.60	10,000	476,045	30,000	Jun 21 09:05 PM
BENDHEIM JACK	President and CEO	Jun 21	Sale	47.60	10,000	476,045	30,000	Jun 21 09:06 PM
BFI Co., LLC	10% Owner	Jun 20	Sale	47.72	10,000	477,200	40,000	Jun 21 09:05 PM
BENDHEIM JACK	President and CEO	Jun 20	Sale	47.72	10,000	477,200	40,000	Jun 21 09:06 PM
BFI Co., LLC	10% Owner	Jun 19	Sale	47.35	10,000	473,500	50,000	Jun 21 09:05 PM
BENDHEIM JACK	President and CEO	Jun 19	Sale	47.35	10,000	473,500	50,000	Jun 21 09:06 PM
BENDHEIM JACK	President and CEO	Jun 13	Sale	46.60	10,000	466,000	30,000	Jun 13 09:09 PM
BFI Co., LLC	10% Owner	Jun 13	Sale	46.60	10,000	466,000	30,000	Jun 13 09:06 PM
BENDHEIM JACK	President and CEO	Jun 12	Sale	46.26	10,000	462,600	40,000	Jun 13 09:09 PM
BFI Co., LLC	10% Owner	Jun 12	Sale	46.26	10,000	462,600	40,000	Jun 13 09:06 PM
BENDHEIM JACK	President and CEO	Jun 11	Sale	46.46	10,000	464,600	17,470	Jun 13 09:09 PM
BFI Co., LLC	10% Owner	Jun 11	Sale	46.46	10,000	464,600	17,470	Jun 13 09:06 PM
BENDHEIM JACK	President and CEO	Jun 07	Sale	46.47	10,000	464,700	27,470	Jun 07 09:09 PM
BFI Co., LLC	10% Owner	Jun 07	Sale	46.47	10,000	464,700	27,470	Jun 07 09:08 PM
BENDHEIM JACK	President and CEO	Jun 06	Sale	45.83	10,000	458,300	37,470	Jun 07 09:09 PM
BFI Co., LLC	10% Owner	Jun 06	Sale	45.83	10,000	458,300	37,470	Jun 07 09:08 PM
BENDHEIM JACK	President and CEO	Jun 05	Sale	45.87	10,000	458,650	47,470	Jun 07 09:09 PM
BFI Co., LLC	10% Owner	Jun 05	Sale	45.87	10,000	458,650	47,470	Jun 07 09:08 PM
BENDHEIM JACK	President and CEO	May 18	Sale	45.05	9,930	447,347	2,070	May 22 09:55 PM
BFI Co., LLC	10% Owner	May 18	Sale	45.05	9,930	447,347	2,070	May 22 09:54 PM
BENDHEIM JACK	President and CEO	Mar 25	Sale	45.05	100	4,505	57,470	May 25 08:13 PM
BFI Co., LLC	10% Owner	Mar 25	Sale	45.05	100	4,505	57,470	May 25 08:12 PM
BENDHEIM JACK	President and CEO	Mar 24	Sale	45.01	600	27,006	57,570	May 25 08:13 PM
BFI Co., LLC	10% Owner	Mar 24	Sale	45.01	600	27,006	57,570	May 25 08:12 PM
BENDHEIM JACK	President and CEO	Mar 23	Sale	45.12	1,900	85,728	58,170	May 25 08:13 PM
BFI Co., LLC	10% Owner	Mar 23	Sale	45.12	1,900	85,728	58,170	May 25 08:12 PM
BFI Co., LLC	10% Owner	Mar 15	Sale	39.98	12,000	479,760	12,000	Mar 16 05:11 PM
BENDHEIM JACK	President and CEO	Mar 15	Sale	39.98	12,000	479,760	12,000	Mar 16 05:08 PM
BFI Co., LLC	10% Owner	Mar 14	Sale	40.12	12,000	481,440	24,000	Mar 16 05:11 PM
BENDHEIM JACK	President and CEO	Mar 14	Sale	40.12	12,000	481,440	24,000	Mar 16 05:08 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 12	Option Exercise	11.83	13,162	155,706	13,162	Mar 12 09:11 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 12	Sale	40.00	13,162	526,480	0	Mar 12 09:11 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 09	Option Exercise	11.83	6,576	77,794	6,576	Mar 12 09:11 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 09	Sale	40.03	6,576	263,237	0	Mar 12 09:11 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 08	Option Exercise	11.83	3,425	40,518	3,425	Mar 12 09:11 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 08	Sale	40.00	3,425	137,000	0	Mar 12 09:11 PM
BFI Co., LLC	10% Owner	Mar 07	Sale	38.92	12,000	467,040	36,000	Mar 07 09:46 PM
BENDHEIM JACK	President and CEO	Mar 07	Sale	38.92	12,000	467,040	36,000	Mar 07 09:45 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 06	Option Exercise	11.83	100	1,183	100	Mar 07 09:47 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 06	Sale	40.15	100	4,015	0	Mar 07 09:47 PM
BFI Co., LLC	10% Owner	Mar 06	Sale	38.75	12,000	464,966	48,000	Mar 07 09:46 PM
BENDHEIM JACK	President and CEO	Mar 06	Sale	38.75	12,000	464,966	48,000	Mar 07 09:45 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 05	Option Exercise	11.83	3,860	45,664	3,860	Mar 07 09:47 PM
Bendheim Daniel M	Exec. VP, Corporate Strategy	Mar 05	Sale	40.06	3,860	154,632	0	Mar 07 09:47 PM
BFI Co., LLC	10% Owner	Mar 05	Sale	39.35	12,000	472,240	60,000	Mar 07 09:46 PM
BENDHEIM JACK	President and CEO	Mar 05	Sale	39.35	12,000	472,240	60,000	Mar 07 09:45 PM
BENDHEIM JACK	President and CEO	Mar 01	Sale	38.20	12,000	458,400	36,000	Mar 01 09:23 PM
BFI Co., LLC	10% Owner	Mar 01	Sale	38.20	12,000	458,400	36,000	Mar 01 09:21 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience